Advertisement
Research Paper| Volume 47, ISSUE 4, P518-527, July 2020

Cardiovascular effects of intravenous vatinoxan (MK-467) in medetomidine–tiletamine–zolazepam anaesthetised red deer (Cervus elaphus)

  • Joy Einwaller
    Affiliations
    Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Vienna, Austria
    Search for articles by this author
  • Johanna Painer
    Affiliations
    Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Vienna, Austria
    Search for articles by this author
  • Marja Raekallio
    Affiliations
    Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
    Search for articles by this author
  • Kristina Gasch
    Affiliations
    Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Vienna, Austria
    Search for articles by this author
  • Flavia Restitutti
    Affiliations
    Clinical Unit of Anaesthesiology and Perioperative Intensive-Care Medicine, University of Veterinary Medicine, Vienna, Vienna, Austria
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.
    Ulrike Auer
    Footnotes
    1 These authors contributed equally to this work.
    Affiliations
    Clinical Unit of Anaesthesiology and Perioperative Intensive-Care Medicine, University of Veterinary Medicine, Vienna, Vienna, Austria
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.
    Gabrielle L. Stalder
    Correspondence
    Correspondence: Gabrielle Stalder, Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Savoyenstr. 1, 1160, Vienna, Austria.
    Footnotes
    1 These authors contributed equally to this work.
    Affiliations
    Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Vienna, Austria
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.
Published:March 29, 2020DOI:https://doi.org/10.1016/j.vaa.2019.10.011

      Abstract

      Objective

      To determine the effect of intravenous vatinoxan administration on bradycardia, hypertension and level of anaesthesia induced by medetomidine–tiletamine–zolazepam in red deer (Cervus elaphus).

      Study design and animals

      A total of 10 healthy red deer were included in a randomised, controlled, experimental, crossover study.

      Methods

      Deer were administered a combination of 0.1 mg kg–1 medetomidine hydrochloride and 2.5 mg kg–1 tiletamine–zolazepam intramuscularly, followed by 0.1 mg kg–1 vatinoxan hydrochloride or equivalent volume of saline intravenously (IV) 35 minutes after anaesthetic induction. Heart rate (HR), mean arterial blood pressure (MAP), respiration rate (fR), end-tidal CO2 (Pe′CO2), arterial oxygen saturation (SpO2), rectal temperature (RT) and level of anaesthesia were assessed before saline/vatinoxan administration (baseline) and at intervals for 25 minutes thereafter. Differences within treatments (change from baseline) and between treatments were analysed with linear mixed effect models (p < 0.05).

      Results

      Maximal (81 ± 10 beats minute–1) HR occurred 90 seconds after vatinoxan injection and remained significantly above baseline (42 ± 4 beats minute–1) for 15 minutes. MAP significantly decreased from baseline (122 ± 10 mmHg) to a minimum MAP of 83 ± 6 mmHg 60 seconds after vatinoxan and remained below baseline until end of anaesthesia. HR remained unchanged from baseline (43 ± 5 beats minute–1) with the saline treatment, whereas MAP decreased significantly (112 ± 16 mmHg) from baseline after 20 minutes. Pe′CO2, fR and SpO2 showed no significant differences between treatments, whereas RT decreased significantly 25 minutes after vatinoxan. Level of anaesthesia was not significantly influenced by vatinoxan.

      Conclusions and clinical relevance

      Vatinoxan reversed hypertension and bradycardia induced by medetomidine without causing hypotension or affecting the level of anaesthesia in red deer. However, the effect on HR subsided 15 minutes after vatinoxan IV administration. Vatinoxan has the potential to reduce anaesthetic side effects in non-domestic ruminants immobilised with medetomidine–tiletamine–zolazepam.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adam M.
        • Raekallio M.R.
        • Salla K.M.
        • et al.
        Effects of the peripherally acting α2-adrenoceptor antagonist MK-467 on cardiopulmonary function in sheep sedated by intramuscular administration of medetomidine and ketamine and reversed by intramuscular administration of atipamezole.
        Am J Vet Res. 2018; 79: 921-932
        • Adam M.
        • Raekallio M.R.
        • Vainio O.M.
        Sedative effect of intramuscular medetomidine with and without vatinoxan (MK-467), and its reversal with atipamezole in sheep.
        Vet Anaesth Analg. 2018; 45: 788-793
        • Arnemo J.M.
        • Storaas T.
        • Khadka C.B.
        • et al.
        Use of medetomidine-ketamine and atipamezole for reversible immobilization of free-ranging hog deer (Axis porcinus) captured in drive nets.
        J Wildl Dis. 2005; 41: 467-470
        • Barasona J.A.
        • López-Olvera J.R.
        • Beltrán-Beck B.
        • et al.
        Trap-effectiveness and response to tiletamine–zolazepam and medetomidine anaesthesia in Eurasian wild boar captured with cage and corral traps.
        BMC Vet Res. 2013; 9: 107
        • Boesch J.M.
        • Boulanger J.R.
        • Curtis P.D.
        • et al.
        Biochemical variables in free-ranging white-tailed deer (Odocoileus Virginianus) after chemical immobilization in clover traps or via ground-darting.
        J Zoo Wildl Med. 2011; 42: 18-28
        • Bryant C.E.
        • Clarke K.W.
        • Thompson J.
        Cardiopulmonary effects of medetomidine in sheep and in ponies.
        Res Vet Sci. 1996; 60: 267-271
        • Bryant C.E.
        • Thompson J.
        • Clarke K.W.
        Characterisation of the cardiovascular pharmacology of medetomidine in the horse and sheep.
        Res Vet Sci. 1998; 65: 149-154
        • Clineschmidt B.V.
        • Pettibone D.J.
        • Lotti V.J.
        • et al.
        A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
        J Pharmacol Exp Ther. 1988; 245: 32-40
        • Cullen L.K.
        • Reynoldson J.A.
        Effects of tiletamine/zolazepam premedication on propofol anaesthesia in dogs.
        Vet Rec. 1997; 140: 363-366
        • de Vries A.
        • Pakkanen S.A.E.
        • Raekallio M.R.
        • et al.
        Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2-adrenoceptor antagonist MK-467 in horses.
        Vet Anaesth Analg. 2016; 43: 599-610
        • Grimm K.A.
        • Lamont L.A.
        Clinical pharmacology.
        in: West G. Heard D. Caulkett N. Zoo Animal and Wildlife Immobilization and Anesthesia. Blackwell Publishing Professional, USA2007: 3-36
        • Heard D.J.
        Monitoring.
        in: West G. Heard D.J. Caulkett N. Zoo Animal & Wildlife Immobilization and Anesthesia. Blackwell, UK2007: 83-91
        • Honkavaara J.
        • Pypendop B.
        • Ilkiw J.
        The impact of MK-467 on sedation, heart rate and arterial blood pressure after intramuscular coadministration with dexmedetomidine in conscious cats.
        Vet Anaesth Analg. 2017; 44: 811-822
        • Honkavaara J.
        • Pypendop B.
        • Turunen H.
        • et al.
        The effect of MK-467, a peripheral α2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia after intravenous administration in conscious cats.
        Vet Anaesth Analg. 2017; 44: 42-51
        • Honkavaara J.
        • Restitutti F.
        • Raekallio M.
        • et al.
        Influence of MK-467, a peripherally acting α2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs.
        Drug Metab Dispos. 2012; 40: 445-449
        • Honkavaara J.M.
        • Raekallio M.R.
        • Kuusela E.K.
        • et al.
        The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs.
        Vet Anaesth Analg. 2008; 35: 409-413
        • Honkavaara J.M.
        • Restitutti F.
        • Raekallio M.R.
        • et al.
        The effects of increasing doses of MK-467, a peripheral alpha2-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs.
        J Vet Pharmacol Therap. 2011; 34: 332-337
        • Kästner S.B.R.
        • Ohlerth S.
        • Pospischil A.
        • et al.
        Dexmedetomidine-induced pulmonary alterations in sheep.
        Res Vet Sci. 2007; 83: 217-226
        • Langer S.Z.
        • Massingham R.
        • Shepperson N.B.
        Presence of postsynaptic α2-adrenoreceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb.
        Clin Sci. 1980; 59: 225s-228s
        • Lenth R.V.
        Least-squares means: the R Package lsmeans.
        J Stat Softw. 2016; 69: 1-33
        • Lin H.C.
        • Thurmon J.C.
        • Benson G.J.
        • et al.
        Review: Telazol – a review of its pharmacology and use in veterinary medicine.
        J Vet Pharmacol Therap. 1993; 16: 383-418
        • Lin H.C.
        • Thurmon J.C.
        • Benson G.J.
        • et al.
        The hemodynamic response of calves to tiletamine–zolazepam anesthesia.
        Vet Surg. 1989; 18: 328-334
        • MacDonald E.
        • Scheinin H.
        • Scheinin M.
        Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative.
        Eur J Pharmacol. 1988; 158: 119-127
        • Masters N.J.F.
        • Flach E.
        Tragulidae, Moschidae, and Cervidae.
        in: Miller R.E. Fowler M.E. Fowler's Zoo and Wild Animal Medicine. 8th edn. Elsevier Saunders, St. Louis. Missouri2015: 611-625
        • Murrell J.C.
        • Hellebrekers L.J.
        Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog.
        Vet Anaesth Analg. 2005; 32: 117-127
        • Pinheiro J.
        • Bates D.
        • DebRoy S.
        • R Core Team
        nlme: linear and nonlinear mixed effects models. R package version 3.1-131.
        2017
        • Pypendop B.H.
        • Honkavaara J.
        • Ilkiw J.E.
        Cardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats.
        Vet Anaesth Analg. 2017; 44: 52-62
        • R Core Team
        R: A language and environment for statistical computing.
        R Foundation for Statistical Computing, Vienna, Austria2017
        • Raekallio M.R.
        • Honkavaara J.M.
        • Vainio O.M.
        The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep.
        J Vet Pharmacol Therap. 2010; 33: 434-438
        • Restitutti F.
        • Kaartinen M.J.
        • Raekallio M.R.
        • et al.
        Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha2-antagonist MK-467 in dogs.
        Vet Anaesth Analg. 2017; 44: 417-426
        • Riebold T.W.
        Ruminants.
        in: Veterinary Anesthesia and Analgesia: The Fifth Edition of Lumb and Jones. (5th edn). Grimm KA, Lamont LA, Tranquilli WJ, et al. John Wiley & Sons, USA2015: 912-927
        • Sainmaa S.
        • Mykkänen A.K.
        • Adam M.
        • et al.
        Intravenous vatinoxan in markhors (Capra falconeri heptneri) immobilized with intramuscular medetomidine and ketamine—a preliminary dose screening study.
        J Zoo Wildlife Med. 2019; 50: 159-166
        • Savola J.M.
        Cardiovascular actions of medetomidine and their reversal by atipamezole.
        Acta Vet Scand Suppl. 1989; 85: 39-47
        • Tapio H.A.
        • Raekallio M.R.
        • Mykkänen A.
        • et al.
        Effects of MK-467 hydrochloride and hyoscine butylbromide on cardiorespiratory and gastrointestinal changes induced by detomidine hydrochloride in horses.
        Am J Vet Res. 2018; 79: 376-387
        • Taylor J.H.
        • Botha C.J.
        • Swan G.E.
        • et al.
        Tiletamine hydrochloride in combination with zolazepam hydrochloride as an anaesthetic agent in sheep.
        J S Afr Vet Assoc. 1992; 63: 63-65
        • Vainionpää M.
        • Salla K.
        • Restitutti F.
        • et al.
        Thermographic imaging of superficial temperature in dogs sedated with medetomidine and butorphanol with and without MK-467 (L-659'066).
        Vet Anaesth Analg. 2013; 40: 142-148
        • Wan P.Y.
        • Trim C.M.
        • Mueller P.O.E.
        Xylazine–ketamine and detomidine–tiletamine–zolazepam anesthesia in horses.
        Vet Surg. 1992; 21: 312-318
        • Williams M.
        • Caulkett N.
        • Neuhaus P.
        • et al.
        Comparison of the efficacy and safety of medetomidine–ketamine versus medetomidine–azaperone–alfaxalone combination in free-ranging Rocky Mountain Bighorn Sheep (Ovis canadensis).
        J Zoo Wildlife Med. 2018; 49: 662-670
        • Yanmaz L.E.
        • Doğan E.Ö.
        • Okumuş Z.
        • et al.
        Comparison of intranasal and intramuscular administration of zolazepam–tiletamine combination in cats.
        Atatürk Üniv Vet Bil Derg. 2017; 12: 124-129